Literature DB >> 19482265

Positive correlation between the density of neuropeptide y positive neurons in the amygdala and parameters of self-reported anxiety and depression in mesiotemporal lobe epilepsy patients.

Christian Frisch1, Joachim Hanke, Sven Kleinerüschkamp, Sandra Röske, Sabine Kaaden, Christian E Elger, Johannes Schramm, Denis M Yilmazer-Hanke, Christoph Helmstaedter.   

Abstract

BACKGROUND: Neuropeptide Y (NPY) has been implicated in depression, anxiety, and memory. Expression of human NPY and the number of NPY-positive neurons in the rodent amygdala correlate with anxiety and stress-related behavior. Increased NPY expression in the epileptic brain is supposed to represent an adaptive mechanism counteracting epilepsy-related hyperexcitability. We attempted to investigate whether NPY-positive neurons in the human amygdala are involved in these processes.
METHODS: In 34 adult epileptic patients undergoing temporal lobe surgery for seizure control, the density of NPY-positive neurons was assessed in the basal, lateral, and accessory-basal amygdala nuclei. Cell counts were related to self-reported depression, anxiety, quality of life, clinical parameters (onset and duration of epilepsy, seizure frequency), antiepileptic medication, and amygdala and hippocampal magnetic resonance imaging volumetric measures.
RESULTS: Densities of NPY-positive basolateral amygdala neurons showed significant positive correlations with depression and anxiety scores, and they were negatively correlated with lamotrigine dosage. In contrast, NPY cell counts showed no relation to clinical factors or amygdalar and hippocampal volumes.
CONCLUSIONS: The results point to a role of amygdalar NPY in negative emotion and might reflect state processes at least in patients with temporal lobe epilepsy. Correlations with common clinical parameters of epilepsy were not found. The question of a disease-related reduction of the density of NPY-positive amygdalar neurons in temporal lobe epilepsy requires further investigation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19482265     DOI: 10.1016/j.biopsych.2009.03.025

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  4 in total

Review 1.  Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?

Authors:  L Cardamone; M R Salzberg; T J O'Brien; N C Jones
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

2.  Functional connectivity abnormalities vary by amygdala subdivision and are associated with psychiatric symptoms in unilateral temporal epilepsy.

Authors:  Gaëlle E Doucet; Christopher Skidmore; Ashwini D Sharan; Michael R Sperling; Joseph I Tracy
Journal:  Brain Cogn       Date:  2013-09-11       Impact factor: 2.310

3.  Specific B- and T-cell populations are associated with cognition in patients with epilepsy and antibody positive and negative suspected limbic encephalitis.

Authors:  Christoph Helmstaedter; Niels Hansen; Pitshaporn Leelaarporn; Kerstin Schwing; Demet Oender; Guido Widman; Attila Racz; Rainer Surges; Albert Becker; Juri-Alexander Witt
Journal:  J Neurol       Date:  2020-08-20       Impact factor: 4.849

4.  Depressive symptoms in patients with epilepsy and clinically associated features in a single tertiary center.

Authors:  Mariacarolina Vacca; Mariana Fernandes; Matteo Spanetta; Fabio Placidi; Francesca Izzi; Caterina Lombardo; Nicola Biagio Mercuri; Claudio Liguori
Journal:  Neurol Sci       Date:  2021-09-15       Impact factor: 3.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.